Organon Tempers Expectations Ahead Of Adalimumab Second Wave

Firm Prepares To Launch Both High- And Low-Concentration US Humira Biosimilars

 
• By David Wallace
  
Skate ramp gradually ramping up
Organon expects a “modest ramp” for Hadlima in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products